Unaudited Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended				9 Months Ended
	Sep. 30, 2021		Sep. 30, 2020		Sep. 30, 2021		Sep. 30, 2020
Revenue	$ 33,800,000	[1]	$ 11,279,000	[2]	$ 81,851,000	[2]	$ 33,361,000	[2]
Costs and operating expenses:
Research and development	3,219,000		1,725,000		8,250,000		4,865,000
Sales and marketing	4,065,000		1,588,000		9,228,000		4,530,000
General and administrative	10,081,000		3,503,000		22,058,000		9,916,000
Intangible asset amortization	2,525,000		706,000		5,340,000		2,100,000
Acquisition costs	345,000		179,000		1,616,000		417,000
Change in fair value of contingent consideration	(140,000)		(2,000)		1,086,000		(1,528,000)
Total operating expenses	44,959,000		12,525,000		98,546,000		34,193,000
Operating loss	(11,159,000)		(1,246,000)		(16,695,000)		(832,000)
Other income (expense):
Change in fair value of warrant liability	0		(1,005,000)		(121,000)		4,467,000
Change in fair value of investments	0		1,110,000		0		1,110,000
Interest (expense) income, net	(194,000)		13,000		(331,000)		59,000
Other expense	(7,000)		(5,000)		(7,000)		(9,000)
Gain on acquisition of Sexton Biotechnologies, Inc.	6,451,000		0		6,451,000		0
Total other income, net	6,250,000		113,000		5,992,000		5,627,000
(Loss) income before income tax benefit	(4,909,000)		(1,133,000)		(10,703,000)		4,795,000
Income tax benefit	4,988,000		0		17,540,000		0
Net income (loss)	79,000		(1,133,000)		6,837,000		4,795,000
Net income (loss) attributable to common shareholders:
Basic	77,000		(1,133,000)		6,621,000		4,322,000
Diluted	$ 77,000		$ (1,133,000)		$ 6,628,000		$ 279,000
Basic (in dollars per share)	$ 0.00		$ (0.04)		$ 0.18		$ 0.17
Diluted (in dollars per share)	$ 0.00		$ (0.04)		$ 0.17		$ 0.01
Weighted average shares used to compute earnings (loss) per share attributable to common shareholders:
Basic (in shares)	40,911,801		31,639,420		37,435,224		25,418,375
Diluted (in shares)	43,296,470		31,639,420		39,984,923		29,412,538
Product [Member]
Revenue	$ 29,201,000		$ 10,804,000		$ 70,445,000		$ 32,020,000
Costs and operating expenses:
Cost of goods and services	21,672,000		4,402,000		43,280,000		12,938,000
Service Revenue [Member]
Revenue	2,250,000		0		6,417,000		0
Costs and operating expenses:
Cost of goods and services	1,768,000		0		4,548,000		0
Rental Revenue [Member]
Revenue	2,349,000		475,000		4,989,000		1,341,000
Costs and operating expenses:
Cost of goods and services	$ 1,424,000		$ 424,000		$ 3,140,000		$ 955,000

[1] 2020 revenue includes service revenue related to SciSafe from October 1, 2020 through December 31, 2020.

[2] 2019 revenue includes automated thawing revenue related to Astero from April 1, 2019 through December 31, 2019; evo shipper rental revenue related to SAVSU from August 8, 2019 through December 31, 2019; and freezer and accessory revenue related to CBS from November 12, 2019 through December 31, 2019.